MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 264 filers reported holding MYRIAD GENETICS INC in Q1 2019. The put-call ratio across all filers is 2.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $5,724,000 | -17.0% | 227,160 | -9.0% | 0.00% | -25.0% |
Q4 2021 | $6,893,000 | -22.5% | 249,757 | -9.4% | 0.00% | -20.0% |
Q3 2021 | $8,897,000 | -24.7% | 275,522 | -28.6% | 0.01% | -28.6% |
Q2 2021 | $11,808,000 | +3.4% | 386,142 | +2.9% | 0.01% | 0.0% |
Q1 2021 | $11,424,000 | +74.9% | 375,187 | +13.6% | 0.01% | +75.0% |
Q4 2020 | $6,531,000 | +121.0% | 330,243 | +45.7% | 0.00% | +100.0% |
Q3 2020 | $2,955,000 | +129.8% | 226,625 | +99.8% | 0.00% | +100.0% |
Q2 2020 | $1,286,000 | -27.3% | 113,443 | -8.2% | 0.00% | -50.0% |
Q1 2020 | $1,768,000 | -68.0% | 123,558 | -39.2% | 0.00% | -50.0% |
Q4 2019 | $5,532,000 | -26.8% | 203,161 | -23.1% | 0.00% | -33.3% |
Q3 2019 | $7,561,000 | -4.1% | 264,110 | -7.0% | 0.01% | -14.3% |
Q2 2019 | $7,888,000 | -37.0% | 283,951 | -24.7% | 0.01% | -36.4% |
Q1 2019 | $12,526,000 | -1.6% | 377,276 | -13.9% | 0.01% | -15.4% |
Q4 2018 | $12,736,000 | -17.9% | 438,103 | +29.9% | 0.01% | -7.1% |
Q3 2018 | $15,520,000 | +22.4% | 337,381 | -0.5% | 0.01% | +16.7% |
Q2 2018 | $12,676,000 | +26.4% | 339,192 | -0.1% | 0.01% | +20.0% |
Q1 2018 | $10,032,000 | -23.0% | 339,481 | -10.5% | 0.01% | -23.1% |
Q4 2017 | $13,026,000 | +1.8% | 379,281 | +7.2% | 0.01% | -7.1% |
Q3 2017 | $12,796,000 | +47.3% | 353,673 | +5.2% | 0.01% | +40.0% |
Q2 2017 | $8,688,000 | +77.7% | 336,234 | +32.1% | 0.01% | +42.9% |
Q1 2017 | $4,889,000 | +160.3% | 254,623 | +126.1% | 0.01% | +133.3% |
Q4 2016 | $1,878,000 | -25.8% | 112,630 | -8.5% | 0.00% | -25.0% |
Q3 2016 | $2,532,000 | -33.0% | 123,049 | -0.4% | 0.00% | -33.3% |
Q2 2016 | $3,780,000 | -39.3% | 123,532 | -25.8% | 0.01% | -40.0% |
Q1 2016 | $6,229,000 | +39.8% | 166,427 | +61.1% | 0.01% | +25.0% |
Q4 2015 | $4,457,000 | +37.8% | 103,277 | +19.7% | 0.01% | +33.3% |
Q3 2015 | $3,235,000 | +125.3% | 86,311 | +104.2% | 0.01% | +100.0% |
Q2 2015 | $1,436,000 | -16.0% | 42,261 | -12.5% | 0.00% | 0.0% |
Q1 2015 | $1,710,000 | +6.8% | 48,291 | +2.7% | 0.00% | 0.0% |
Q4 2014 | $1,601,000 | -4.0% | 47,018 | +8.8% | 0.00% | -25.0% |
Q3 2014 | $1,667,000 | -2.6% | 43,218 | -1.7% | 0.00% | 0.0% |
Q2 2014 | $1,712,000 | +39.6% | 43,984 | +22.6% | 0.00% | +33.3% |
Q1 2014 | $1,226,000 | +143.3% | 35,862 | +49.2% | 0.00% | +200.0% |
Q4 2013 | $504,000 | -62.4% | 24,034 | -57.8% | 0.00% | -75.0% |
Q3 2013 | $1,339,000 | -32.3% | 56,969 | -22.6% | 0.00% | -33.3% |
Q2 2013 | $1,978,000 | – | 73,600 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |